6th Mar 2014 10:57
Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
GlaxoSmithKline Deferred Annual Bonus Plan
Withholding of shares to meet tax liabilities
The table below sets out changes in the interests of PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a fair market value of $55.80 per ADS to meet tax liabilities following the vesting of the post-tax awards granted under the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (DABP). Vesting of these awards was announced on 14 February 2014 following the date the Remuneration Committee determined the level of vesting. These post-tax awards formally vested on the third anniversary of the award date which was 4 March 2014.
Number of ADSs withheld to meet tax liabilities following the vesting of a DABP award | |
Ms D Connelly | 123 |
Mr W Louv | 308 |
The Company and the PDMRs were advised of these transactions on 5 March 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
6 March 2014
Related Shares:
Glaxosmithkline